" Application of Art Therapy in Oncology: Evaluation of the Symptomatic of Patients Suffering From a Cancerous Disease"
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Therapy-Associated Cancer
- Sponsor
- Centre Hospitalier de Perigueux
- Enrollment
- 86
- Locations
- 1
- Primary Endpoint
- Evolution well-being felt
- Last Updated
- 4 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the impact of art-therapeutic management on a patient with cancer, during chemotherapy treatment, on the reduction of physical or psychological symptoms.
Art therapy is a non-drug approach that can help some patients cope with the consequences of cancer beyond the care provided.
The common psychosocial difficulties experienced by cancer patients are pain, fatigue, depression, anxiety, drowsiness. In sum, the well-being and quality of life of the patient throughout the illness.
The main objective is to evaluate the impact of art therapy, as a supportive care, on improving the well-being felt after a session of cancer treatments (chemotherapy, immunotherapy, ...), during 6 sessions( around 24 days between 2 sessions) , at patients with a cancer pathology using two questionnaires, one on the evaluation of symptoms (ESAS), the other on the quality of life (FACT-G).
Detailed Description
Patients will be randomized into the following groups: * Group 1: Art therapy as supportive care in 6 consecutive sessions of cancer treatments with or without additional supportive care * Group 2: 6 consecutive sessions of cancer treatments with or without additional supportive care. Symptom assessment with the Edmonton Symptom Assessment System (ESAS) is done before and after each treatment session for each patient. The FACT-G questionnaire on the quality of life at the beginning and the end of the care for the two groups (group benefiting from the art-therapy and group not benefiting from the art-therapy) and a questionnaire on the contribution of art therapy, at the end of care, for the participants of the art-therapy group.
Investigators
Elodie Barbut Paillard
Principal investigator
Centre Hospitalier de Perigueux
Eligibility Criteria
Inclusion Criteria
- •aged over 18
- •patient cared for on Onco-hematology day with a cancerous pathology
- •consent of the patient
- •patient affiliated to social Security
Exclusion Criteria
- •patient minor
- •patient under legal protection
- •patient with too much impairment of vital and / or cognitive functions to participate and understand the study
- •patient whose predictable management is less than the follow-up period (6 sessions),
- •patient who has already participated in an art therapy session during their lifetime
Outcomes
Primary Outcomes
Evolution well-being felt
Time Frame: Before and after each chimotherapy session - 6 sessions between 6 weeks to 6 months
The aim is to evaluate the impact of art therapy as a supportive care on the improvement of the well-being felt after a session of cancer treatments (chemotherapy, immunotherapy, ...), during 6 sessions, in patients having a cancerous pathology. The primary endpoint is the 6-session average of the difference between the ESAS score associated with the patient's well-being symptom (a symptom of "feeling good" on the ESAS assessment), obtained before and after the treatment session. The Edmonton Symptom Assessment System (SESA) is a 9-item symptom rating scale. The quote goes from 0 to 10. A score close to zero means a better result. The comparison of the mean differences between the ESAS score before and after each of the six cancer treatment sessions according to the two randomization groups will be performed using a generalized linear model.
Secondary Outcomes
- evaluation of all items on the ESAS scale along 6 sessions(Before and after each chemotherapy session - 6 sessions between 6 weeks to 6 months)
- evaluation of all items on the ESAS scale between first and last session(6 sessions between 6 weeks to 6 months)
- art therapy satisfaction questionary(End of 6 session between 6 weeks to 6 months)
- evolution of the Fact G quality of life assessment items(6 sessions between 6 weeks to 6 months)